Urgent Signs: When Adopted Dog Lumps Need Immediate Vet Care

When a Lump in an Adopted Dog Needs Immediate Veterinary Attention

Adopted dogs often arrive with limited medical history, making it crucial to recognize which lumps are harmless and which demand urgent care. Not every swelling is lymphoma, but certain characteristics should trigger a prompt veterinary visit.

• Firm, enlarged nodes in typical lymph‑node locations (under the jaw, shoulder, armpit, groin, or behind the knee)
• Multiple enlarged nodes or a rapidly growing single mass
• Associated systemic signs such as lethargy, weight loss, poor appetite, fever, vomiting, diarrhea, excessive thirst or urination, coughing, or breathing difficulty
• Signs of severe illness: pale or yellow gums, bruising, bleeding, collapse, severe pain, or marked abdominal distension

Any of the above, especially when combined, warrants a same‑day or emergency assessment. In contrast, a soft, movable, stable lump that feels like a fatty lipoma can be scheduled for a routine exam, but should still be evaluated to rule out hidden disease.

Common Forms of Canine Lymphoma

The most important biological split is B‑cell vs. T‑cell lymphoma. B‑cell disease is more common and typically responds better to chemotherapy, while T‑cell disease tends to be more aggressive, often associated with high blood calcium, and carries a shorter remission time.

First Veterinary Evaluation: What to Expect

A thorough initial visit will usually include:

• Complete physical exam with measurement of all accessible lymph nodes
• Body‑condition scoring, hydration check, temperature, gum color, abdominal palpation, and respiratory assessment
• Complete blood count (CBC) and serum chemistry panel (including calcium, liver and kidney values, proteins, glucose)
• Urinalysis
• Screening for infections or regional diseases that can cause node enlargement

Blood work does not diagnose lymphoma on its own, but it helps identify complications (anemia, hypercalcemia, organ dysfunction) and determines whether the dog is a safe candidate for sedation or chemotherapy.

Fine‑Needle Aspirate (FNA): The First Diagnostic Step

FNA uses a thin needle to collect cells from an enlarged node or mass—often performed without general anesthesia. The sample is examined by a cytologist, and results fall into four categories:

• Diagnostic lymphoma – clear abnormal lymphocytes, allowing treatment planning to begin.
• Reactive/inflammatory node – no cancer identified, but lymphoma not fully excluded.
• Non‑diagnostic sample – insufficient cells; may need repeat FNA, flow cytometry, core biopsy, or excisional biopsy.
• Suspicious but uncertain – additional testing required.

A negative or equivocal FNA does not guarantee the absence of lymphoma; low‑grade disease, necrosis, or sampling error can obscure the diagnosis.

Advanced Tests to Refine the Diagnosis

• Flow cytometry – identifies B‑cell or T‑cell lineage by surface proteins.
• Immunocytochemistry / immunohistochemistry – uses antibodies to classify tumor cells.
• PARR (PCR for Antigen Receptor Rearrangement) – detects clonal lymphoid populations.
• Biopsy and histopathology – evaluates tissue architecture, cell size, grade, and exact subtype, especially for low‑grade or extranodal disease.

Staging Workup: How Widely Is the Cancer Spread?

Staging determines the extent of disease and guides treatment intensity. The five‑stage system most vets use is:

1. Stage I: single lymph node or single organ
2. Stage II: multiple nodes on one side of the diaphragm or a regional chain
3. Stage III: generalized lymph‑node involvement
4. Stage IV: generalized nodes plus liver and/or spleen
5. Stage V: blood, bone‑marrow, or other organ involvement

Each stage is further divided into:

• Substage a – dog appears clinically well aside from lymphoma.
• Substage b – systemic illness present (fever, weight loss, GI signs, respiratory signs, hypercalcemia, etc.).

Typical staging tests include CBC, chemistry, calcium, urinalysis, thoracic radiographs, abdominal ultrasound, and—when indicated—bone‑marrow aspirates or liver/spleen biopsies. Not every dog needs every test; staging is most valuable when it changes the therapeutic plan, provides a baseline, or clarifies prognosis.

Treatment Options for Canine Lymphoma

CHOP or L‑CHOP Chemotherapy (Standard of Care)

The multi‑agent protocol that most oncologists recommend for high‑grade multicentric lymphoma combines:

• Cyclophosphamide
• Hydroxydaunorubicin (doxorubicin)
• Oncovin (vincristine)
• Prednisone
• Often L‑asparaginase is added, creating an “L‑CHOP” regimen.

A full course typically spans 19–25 weeks, with treatments every 1–3 weeks and frequent blood‑count checks. Reported response rates are 70‑90 %, and many dogs achieve a complete remission—meaning palpable nodes return to normal size and clinical signs disappear.

Side effects are usually mild to moderate because veterinary protocols prioritize quality of life:

• Transient loss of appetite, vomiting, or diarrhea
• Lethargy
• Temporary neutropenia (low white‑cell count) with infection risk
• Hair thinning in some breeds
• Rare organ‑specific toxicity (e.g., heart concerns with doxorubicin)

Owners should contact the oncology team immediately if the dog develops fever, severe lethargy, uncontrolled vomiting/diarrhea, or refuses to eat.

Less Intensive or Alternative Protocols

• COP (cyclophosphamide, vincristine, prednisone) – lower intensity, shorter remission.
• Single‑agent doxorubicin or lomustine – useful for selected T‑cell or cutaneous cases.
• Oral chlorambucil or other low‑dose regimens for indolent lymphomas.
• Radiation therapy – for localized disease or palliation.
• Surgery – rarely curative for multicentric disease but may be needed for obstruction or diagnosis.
• Rescue chemotherapy – after relapse, often a different drug combination.
• Prednisone alone – provides temporary shrinkage of nodes but can mask diagnostic cells; should be used only when chemotherapy is not an option.

Remission, Relapse, and Survival Timelines

With CHOP‑based therapy:

• Most dogs enter remission within the first few treatments (often 2‑4 weeks).
• Median first remission lasts 5–12 months, varying by immunophenotype, stage, and individual response.
• The entire CHOP protocol itself lasts about 5–6 months.
• Relapse is common; after a first remission, median time to relapse is typically 6‑9 months.
• Rescue protocols can induce another remission, usually lasting 1.5–2.5 months, though results are highly individual.

These numbers are population medians; some dogs exceed them dramatically, especially B‑cell cases with favorable biology and diligent supportive care.

Prognosis: What Factors Matter Most?

• Immunophenotype – B‑cell disease generally yields median survival ~12 months; T‑cell disease ~6‑9 months.
• Histologic grade and subtype – high‑grade large‑cell lymphomas respond quickly but may relapse early; low‑grade forms progress slowly.
• Stage and substage – higher stage or substage b (systemic illness) shortens expected survival.
• Hypercalcemia – often indicates T‑cell disease and worsens outlook.
• Initial response to chemotherapy – dogs achieving a complete remission have longer survival.
• Prednisone use before diagnosis – can diminish cytology accuracy and lower chemotherapy efficacy.
• Overall health and organ function – kidney or liver disease may limit drug choices.

Remember, these are averages; an individual dog’s journey can differ based on genetics, supportive care, and the owner’s treatment goals.

2026 Cost Ranges for Canine Lymphoma Care (U.S.)